| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |